One-Stop Shop: EU Devices And Diagnostics Regulatory Outlook Through May 2021
Change, change and more change: Is timely compliance with the EU's MDR and IVDR still possible?
Executive Summary
The end of the traditional EU holiday period is nearing, and the pace of regulatory activity is expected to pick up sharply as September gets underway. What can medtech expect for the rest of 2020 and into the first half of 2021, in these unprecedented times?
You may also be interested in...
UKCA Mark Will Be The Post-EU Route To The British Medtech Market In January 2021
New MHRA guidance says the EU CE marking will continue to be used for devices and diagnostics in Great Britain until June 2023, and thereafter a standalone regulatory system will come into place.
Competent Authorities Warn EU Industry Not To Expect All MDR Implementation Tools In Time
Preparing all items needed to support the implementation of the EU’s Medical Device and IVD Regulations in time is going to be impossible. Competent authority expert Thomas W Møller explains how work on a third of implementation tasks still remains to be started.
EU’s MDR One-Year Delay Now Official As Amending Regulation Is Published In EU Official Journal
The EU medtech industry's hard-fought battle for a one-year delay to the Medical Device Regulation is now reality. While COVID-19 was the deciding factor in the EU decision, it is what the industry has been lobbying for over the past year.